Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
Michael Dickinson, Javier Briones, Alex F Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, Izolda Franjkovic, Evelyne Chesne, Jurriaan Brouwer-Visser, Katharina Lechner, Barbara Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings
Dyk ned i forskningsemnerne om 'Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma'. Sammen danner de et unikt fingeraftryk.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science